Human Liver Model Market to Grow with a CAGR of 4.17% through 2028

The prevalence of liver diseases, technological breakthroughs, and the rise of personalized medicine are expected to drive the Global Human Liver Model Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Human Liver Model Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Human Liver Model Market stood at USD 567.45 million in 2022 and is anticipated to grow with a CAGR of 4.17% in the forecast period, 2024-2028. This can be attributed to industry collaborations and partnerships. Collaboration between academic institutions, pharmaceutical companies, and biotech firms has accelerated the development and adoption of human liver models. Partnerships leverage complementary expertise and resources to advance research and bring innovative models to market more quickly.

Furthermore, ethical concerns and the desire for more humane research practices are pushing the reduction of animal testing. Human liver models serve as ethical alternatives, offering a way to obtain human-specific data without harming animals. The trend toward reducing animal testing is expected to accelerate the adoption of these models.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Human Liver Model Market”

The global market for human liver models is poised for substantial growth in the foreseeable future. This expansion can be primarily attributed to the escalating investment in healthcare research and development, the rising incidence of liver diseases, and the continuous advancements in organ printing technologies. Furthermore, the growing emphasis on developing alternatives to animal-based models for more precise research outcomes is expected to drive market growth. Additionally, the increasing prevalence of non-alcoholic fatty liver disease and the adverse effects of alcohol consumption leading to liver diseases are anticipated to further stimulate market growth in the coming years. Nevertheless, challenges such as the high cost of liver models and the complexities associated with integrating these models into existing workflows are likely to hinder market growth during the forecast period.

The Global Human Liver Model Market is segmented into product, application, regional distribution, and company

Based on its product, 2D Models are poised to maintain their dominance in the Global Human Liver Model Market for several compelling reasons. Firstly, they offer cost-effective and efficient solutions for studying liver-related diseases and drug testing, making them an attractive choice for both research institutions and pharmaceutical companies. Moreover, 2D Models have been widely adopted and validated over the years, establishing a robust foundation for continued use. Their simplicity and ease of use also contribute to their enduring popularity. Furthermore, as advancements in cell culture techniques and assay development continue to enhance the relevance and accuracy of 2D Models, they are likely to remain the go-to choose for liver research. In the coming years, the growing demand for liver-related studies and the practical advantages of 2D Models are expected to cement their dominant position in the market.

Based on application, Drug discovery is poised to continue dominating the Global Human Liver Model Market for several compelling reasons. First and foremost, the pharmaceutical industry's unceasing quest for innovative and effective therapies drives a constant demand for reliable liver models to assess drug candidates. Human liver models play an irreplaceable role in early-stage drug testing, enabling researchers to evaluate drug metabolism, toxicity, and efficacy accurately. Moreover, the increasing complexity of drug targets and the push towards personalized medicine necessitate more sophisticated liver models, positioning drug discovery as a key driver of innovation in this market. With ongoing advancements in tissue engineering and biotechnology, drug discovery will likely maintain its dominance in the coming years, ensuring that the Global Human Liver Model Market continues to thrive.

Major companies operating in Global Human Liver Model Market are:

• Organovo Holdings Inc
• BioIVT LLC
• InSphero AG
• Emulate Inc
• Mimetas BV
• CN Bio
• Cyfuse Biomedical KK
• Hurel Corp

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The Global Human Liver Model Market is on the cusp of significant transformation, driven by emerging trends that promise to reshape the landscape of pharmaceutical research and drug development. Integration of AI, multi-organ-on-a-chip systems, patient-derived models, advanced tissue engineering, microfluidic devices, collaborative research initiatives, and regulatory acceptance are poised to revolutionize the industry,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Human Liver Model Market By Product (2D Models, 3D Bio Printing, Liver Organoids), By Application (Drug Discovery, Academics & Research), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Human Liver Model Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Human Liver Model Market.

Contact

Mr. Ken Mathews         

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656                                                     

Email: [email protected]               

Website: www.techsciresearch.com